Skip to main content
. 2022 Apr 18;11(4):535. doi: 10.3390/antibiotics11040535

Figure 2.

Figure 2

Quarterly prevalence of multidrug-resistant bacteria isolates from surveillance samples: (a) prevalence in wards; (b) prevalence in ICUs. MRSA, methicillin-resistant Staphylococcus aureus; VRE, vancomycin-resistant Enterococcus; CRE, carbapenem-resistant Enterobacteriaceae; CRAB, carbapenem-resistant Acinetobacter baumannii; CRPA, carbapenem-resistant Pseudomonas aeruginosa; ICU, intensive care unit.